Switch to
More onapp

Alpa Laboratories Ltd

ALPA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹132 cr, stock is ranked 2,050
High RiskStock is 3.64x as volatile as Nifty
63.450.35 (+0.55%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹132 cr, stock is ranked 2,050
High RiskStock is 3.64x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
9.42
PB RatioPB Ratio
1.09
Dividend YieldDiv. Yield
Sector PESector PE
35.64
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.

Financial TrendFinancial statements 

201920202021202283.2988.88101.95123.051.011.847.2414.10
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 24, 2022

Alpa Laboratories Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Alpa Laboratories Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Outcome of Board Meeting 
Announced OnNov 14, 2022

Alpa Laboratories Limited has informed the Exchange about Board Meeting held on 14-Nov-2022 to consider financial statements for the period ended September 2022 | Download

Alpa Laboratories Limited has informed the Exchange about Board Meeting held on 14-Nov-2022 to consider financial statements for the period ended September 2022 | Download

See all events